Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by BLSH101on Sep 10, 2018 6:07pm
250 Views
Post# 28593588

HUGE FSD PHARMA?!!

HUGE FSD PHARMA?!!
 

HUGE ?!?!? FSD PHARMA

Are you kidding me?? Look at this rocket...

Article on HUGE

FSD Pharma (OTC PINK: FSDDF) (HUGE.CN) reported its financial and operational results for the second quarter of fiscal 2018, ended June 30th, 2018. According to its filings, the company maintained a balance sheet with cash of $31,700,000, no debt, and stronger asset holdings. FSD is said to be aiming for a total grow capacity in excess of 3,000,000 square feet. The company also is expecting an annual output of 400,000,000 grams of which FSD Pharma would benefit 200,000,000 grams.

FSD Pharma through its wholly owned subsidiary FV Pharma is a licensed producer of marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) having received its cultivation license on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour's drive from Toronto, FV Pharma management's mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world.

Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.weed&postid=28593567#1goAoleqMPycWjYg.99

HUGE ?!?!? FSD PHARMA

Are you kidding me?? Look at this rocket...

Article on HUGE

FSD Pharma (OTC PINK: FSDDF) (HUGE.CN) reported its financial and operational results for the second quarter of fiscal 2018, ended June 30th, 2018. According to its filings, the company maintained a balance sheet with cash of $31,700,000, no debt, and stronger asset holdings. FSD is said to be aiming for a total grow capacity in excess of 3,000,000 square feet. The company also is expecting an annual output of 400,000,000 grams of which FSD Pharma would benefit 200,000,000 grams.

FSD Pharma through its wholly owned subsidiary FV Pharma is a licensed producer of marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) having received its cultivation license on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour's drive from Toronto, FV Pharma management's mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world.

Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.weed&postid=28593567#1goAoleqMPycWjYg.99
Bullboard Posts